Semiconductors Healthcare Sector

Tevogen Bio Holdings

Market Cap: US$213.3m

A clinical-stage specialty immunotherapy company, develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders.

Amarin

Market Cap: US$212.7m

A pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally.

Kodiak Sciences

Market Cap: US$212.1m

A clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases.

Codexis

Market Cap: US$212.1m

Provides enzymatic solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, and enhance novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China.

Cidara Therapeutics

Market Cap: US$212.1m

Operates as a biotechnology company that focuses on developing targeted therapies for patients facing cancers and other serious diseases.

BioStem Technologies

Market Cap: US$211.0m

A life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services.

Acelyrin

Market Cap: US$210.5m

A clinical biopharma company, focuses on identifying, acquiring, and accelerating the development and commercialization of transformative medicines.

SOPHiA GENETICS

Market Cap: US$208.5m

Operates as a cloud-native software technology company in the healthcare space.

Orthocell

Market Cap: AU$323.0m

A regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia, the United States, the United Kingdom, and the European Union.

VitaSpring Biomedical

Market Cap: US$207.0m

Focuses on the development of drugs of cell medicine.

AirSculpt Technologies

Market Cap: US$206.9m

Focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States, Canada, and the United Kingdom.

Monopar Therapeutics

Market Cap: US$206.7m

A clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States.

Ocugen

Market Cap: US$205.2m

A biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies, biologic, and vaccines that improve patients’ health.

OptimizeRx

Market Cap: US$203.6m

A digital health technology company, engages in the provision of tech-enabled marketing solutions for life sciences organizations, healthcare providers, and patients.

Integrated Diagnostics Holdings

Market Cap: US$203.5m

Operates as a consumer healthcare company that provides medical diagnostics services to patients.

Tenax Therapeutics

Market Cap: US$203.3m

A clinical-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States.

Design Therapeutics

Market Cap: US$202.7m

A clinical-stage biopharmaceutical company, research, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States.

Performant Healthcare

Market Cap: US$202.0m

Provides audit, recovery, and analytics services in the United States.

CytomX Therapeutics

Market Cap: US$201.6m

Operates as an oncology-focused biopharmaceutical company that focuses on developing novel conditionally activated biologics localized to the tumor microenvironment.

Oncology Institute

Market Cap: US$200.7m

An oncology company, provides various medical oncology services in the United States.

Nuvectis Pharma

Market Cap: US$199.2m

A clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology.

OraSure Technologies

Market Cap: US$198.2m

Develops, manufactures, markets, sells, and distributes diagnostic products, specimen collection devices, and other diagnostic products in the United States, Europe, Africa, and internationally.

Electromed

Market Cap: US$195.4m

Develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally.

Silence Therapeutics

Market Cap: US$194.1m

A biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases.

Bioventix

Market Cap: UK£146.3m

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.

ME Therapeutics Holdings

Market Cap: CA$269.8m

A preclinical stage biotechnology company, engages in the development of cancer fighting drugs in the field of immuno-oncology.

Annexon

Market Cap: US$192.0m

A clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases.

biote

Market Cap: US$191.7m

Operates in practice-building business within the hormone optimization space.

4basebio

Market Cap: UK£144.1m

Engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and targeted non-viral vector solutions in the United States, Europe, and internationally.

Perspective Therapeutics

Market Cap: US$189.3m

Develops and commercializes precision targeted alpha therapies (TAT) to treat cancer in the United States.

Y-mAbs Therapeutics

Market Cap: US$188.4m

A commercial-stage biopharmaceutical company, focuses on the development and commercialization of radioimmunotherapy and antibody based therapeutic products for the treatment of cancer.

Actuate Therapeutics

Market Cap: US$188.3m

A clinical-stage biopharmaceutical company, develops therapies for the treatment of cancers in the United States.

INmune Bio

Market Cap: US$187.1m

A clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease in the United States.

AVITA Medical

Market Cap: US$185.3m

Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.

NervGen Pharma

Market Cap: CA$258.4m

A clinical-stage biotech company together with its subsidiaries, engages in the discovery, development, and commercialization of pharmaceutical treatments for medical conditions related to nervous system damage.

High Tide

Market Cap: CA$258.2m

Engages in the cannabis retail business in Canada, the United States, and internationally.